156 related articles for article (PubMed ID: 16873891)
1. Monolysocardiolipin in cultured fibroblasts is a sensitive and specific marker for Barth Syndrome.
van Werkhoven MA; Thorburn DR; Gedeon AK; Pitt JJ
J Lipid Res; 2006 Oct; 47(10):2346-51. PubMed ID: 16873891
[TBL] [Abstract][Full Text] [Related]
2. Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis.
Valianpour F; Mitsakos V; Schlemmer D; Towbin JA; Taylor JM; Ekert PG; Thorburn DR; Munnich A; Wanders RJ; Barth PG; Vaz FM
J Lipid Res; 2005 Jun; 46(6):1182-95. PubMed ID: 15805542
[TBL] [Abstract][Full Text] [Related]
3. Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome.
Houtkooper RH; Rodenburg RJ; Thiels C; van Lenthe H; Stet F; Poll-The BT; Stone JE; Steward CG; Wanders RJ; Smeitink J; Kulik W; Vaz FM
Anal Biochem; 2009 Apr; 387(2):230-7. PubMed ID: 19454236
[TBL] [Abstract][Full Text] [Related]
4. Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts.
Mejia EM; Zegallai H; Bouchard ED; Banerji V; Ravandi A; Hatch GM
J Biol Chem; 2018 May; 293(20):7564-7577. PubMed ID: 29563154
[TBL] [Abstract][Full Text] [Related]
5. Bloodspot assay using HPLC-tandem mass spectrometry for detection of Barth syndrome.
Kulik W; van Lenthe H; Stet FS; Houtkooper RH; Kemp H; Stone JE; Steward CG; Wanders RJ; Vaz FM
Clin Chem; 2008 Feb; 54(2):371-8. PubMed ID: 18070816
[TBL] [Abstract][Full Text] [Related]
6. Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype.
Bowron A; Honeychurch J; Williams M; Tsai-Goodman B; Clayton N; Jones L; Shortland GJ; Qureshi SA; Heales SJ; Steward CG
J Inherit Metab Dis; 2015 Mar; 38(2):279-86. PubMed ID: 25112388
[TBL] [Abstract][Full Text] [Related]
7. Aberrant cardiolipin metabolism is associated with cognitive deficiency and hippocampal alteration in tafazzin knockdown mice.
Cole LK; Kim JH; Amoscato AA; Tyurina YY; Bay R H; Karimi B; Siddiqui TJ; Kagan VE; Hatch GM; Kauppinen TM
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3353-3367. PubMed ID: 30055293
[TBL] [Abstract][Full Text] [Related]
8. Phospholipid abnormalities in children with Barth syndrome.
Schlame M; Kelley RI; Feigenbaum A; Towbin JA; Heerdt PM; Schieble T; Wanders RJ; DiMauro S; Blanck TJ
J Am Coll Cardiol; 2003 Dec; 42(11):1994-9. PubMed ID: 14662265
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of Barth syndrome using a novel LC-MS/MS method for leukocyte cardiolipin analysis.
Bowron A; Frost R; Powers VE; Thomas PH; Heales SJ; Steward CG
J Inherit Metab Dis; 2013 Sep; 36(5):741-6. PubMed ID: 23109063
[TBL] [Abstract][Full Text] [Related]
10. Quantitative and compositional study of cardiolipin in platelets by electrospray ionization mass spectrometry: application for the identification of Barth syndrome patients.
Valianpour F; Wanders RJ; Barth PG; Overmars H; van Gennip AH
Clin Chem; 2002 Sep; 48(9):1390-7. PubMed ID: 12194913
[TBL] [Abstract][Full Text] [Related]
11. Promotion of plasmalogen biosynthesis reverse lipid changes in a Barth Syndrome cell model.
Bozelli JC; Lu D; Atilla-Gokcumen GE; Epand RM
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jun; 1865(6):158677. PubMed ID: 32126285
[TBL] [Abstract][Full Text] [Related]
12. An improved functional assay in blood spot to diagnose Barth syndrome using the monolysocardiolipin/cardiolipin ratio.
Vaz FM; van Lenthe H; Vervaart MAT; Stet FS; Klinkspoor JH; Vernon HJ; Goorden SMI; Houtkooper RH; Kulik W; Wanders RJA
J Inherit Metab Dis; 2022 Jan; 45(1):29-37. PubMed ID: 34382226
[TBL] [Abstract][Full Text] [Related]
13. Monolysocardiolipin (MLCL) interactions with mitochondrial membrane proteins.
Duncan AL
Biochem Soc Trans; 2020 Jun; 48(3):993-1004. PubMed ID: 32453413
[TBL] [Abstract][Full Text] [Related]
14. When silence is noise: infantile-onset Barth syndrome caused by a synonymous substitution affecting TAZ gene transcription.
Ferri L; Dionisi-Vici C; Taurisano R; Vaz FM; Guerrini R; Morrone A
Clin Genet; 2016 Nov; 90(5):461-465. PubMed ID: 26853223
[TBL] [Abstract][Full Text] [Related]
15. Anomalous peroxidase activity of cytochrome c is the primary pathogenic target in Barth syndrome.
Kagan VE; Tyurina YY; Mikulska-Ruminska K; Damschroder D; Vieira Neto E; Lasorsa A; Kapralov AA; Tyurin VA; Amoscato AA; Samovich SN; Souryavong AB; Dar HH; Ramim A; Liang Z; Lazcano P; Ji J; Schmidtke MW; Kiselyov K; Korkmaz A; Vladimirov GK; Artyukhova MA; Rampratap P; Cole LK; Niyatie A; Baker EK; Peterson J; Hatch GM; Atkinson J; Vockley J; Kühn B; Wessells R; van der Wel PCA; Bahar I; Bayir H; Greenberg ML
Nat Metab; 2023 Dec; 5(12):2184-2205. PubMed ID: 37996701
[TBL] [Abstract][Full Text] [Related]
16. Loss of tafazzin results in decreased myoblast differentiation in C2C12 cells: A myoblast model of Barth syndrome and cardiolipin deficiency.
Lou W; Reynolds CA; Li Y; Liu J; Hüttemann M; Schlame M; Stevenson D; Strathdee D; Greenberg ML
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):857-865. PubMed ID: 29694924
[TBL] [Abstract][Full Text] [Related]
17. Barth syndrome in a female patient.
Cosson L; Toutain A; Simard G; Kulik W; Matyas G; Guichet A; Blasco H; Maakaroun-Vermesse Z; Vaillant MC; Le Caignec C; Chantepie A; Labarthe F
Mol Genet Metab; 2012 May; 106(1):115-20. PubMed ID: 22410210
[TBL] [Abstract][Full Text] [Related]
18. Barth syndrome cells display widespread remodeling of mitochondrial complexes without affecting metabolic flux distribution.
Chatzispyrou IA; Guerrero-Castillo S; Held NM; Ruiter JPN; Denis SW; IJlst L; Wanders RJ; van Weeghel M; Ferdinandusse S; Vaz FM; Brandt U; Houtkooper RH
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3650-3658. PubMed ID: 30251684
[TBL] [Abstract][Full Text] [Related]
19. Linoleic acid supplementation of Barth syndrome fibroblasts restores cardiolipin levels: implications for treatment.
Valianpour F; Wanders RJ; Overmars H; Vaz FM; Barth PG; van Gennip AH
J Lipid Res; 2003 Mar; 44(3):560-6. PubMed ID: 12562862
[TBL] [Abstract][Full Text] [Related]
20. Cardiolipin deficiency in X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060): a study in cultured skin fibroblasts.
Valianpour F; Wanders RJ; Overmars H; Vreken P; Van Gennip AH; Baas F; Plecko B; Santer R; Becker K; Barth PG
J Pediatr; 2002 Nov; 141(5):729-33. PubMed ID: 12410207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
